Systemic delivery of shRNA by AAV9 provides highly efficient knockdown of ubiquitously expressed GFP in mouse heart, but not liver.
AAV9 is a powerful gene delivery vehicle capable of providing long-term gene expression in a variety of cell types, particularly cardiomyocytes. The use of AAV-delivery for RNA interference is an intense area of research, but a comprehensive analysis of knockdown in cardiac and liver tissues after s...
Guardado en:
Autores principales: | Bryan A Piras, Daniel M O'Connor, Brent A French |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea7081d2ad78426c926c7082a3337f57 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inducible transgenic rat model for diabetes mellitus based on shRNA-mediated gene knockdown.
por: Katarina Kotnik, et al.
Publicado: (2009) -
Optimized PCR conditions and increased shRNA fold representation improve reproducibility of pooled shRNA screens.
por: Žaklina Strezoska, et al.
Publicado: (2012) -
Systemic AAV6-synapsin-GFP administration results in lower liver biodistribution, compared to AAV1&2 and AAV9, with neuronal expression following ultrasound-mediated brain delivery
por: Danielle Weber-Adrian, et al.
Publicado: (2021) -
Functional selection of shRNA loops from randomized retroviral libraries.
por: Stig Mølgaard Rask Jensen, et al.
Publicado: (2012) -
shRNA transgenic swine display resistance to infection with the foot-and-mouth disease virus
por: Wenping Hu, et al.
Publicado: (2021)